Abstract
Purpose:
We evaluated the effects of intra-arterial infusion therapy by comparing the results obtained with a combination of intra-arterial anticancer drugs with and without transcatheter arterial embolization (TAE) in patients with cervical cancer.
Methods:
Between April 1999 and March 2003, intra-arterial therapy was administered to 45 patients (mean age 49 years) with cervical cancer. Of these, 18 had stage IIb , 4 had stage IIIa, 19 had stage IIIb, and 4 had stage IVb cancer; the histopathologic types were squamous cell carcinoma (n = 35), adenocarcinoma (n = 8), and adenosquamous carcinoma (n = 2). A total of 45 patients gave their informed consent and were randomized on a continuous basis into one of three groups according to the therapeutic protocols: group A consisted of 15 patients who received cisplatin, group B consisted of 17 patients who received cisplatin, mitomycin, doxorubicin hydrochloride, and 5-fluorouracil, and group C consisted of 13 patients who received cisplatin and TAE. Each protocol was administered twice with a 3 week interval between treatments. The efficacy of treatment was evaluated on the basis of the tumor reduction ratio (%) using MR imaging and the side effects were analyzed.
Results:
In groups A, B, and C, the tumor reduction ratio was 54%, 84%, and 86%, respectively; it was significantly greater in groups B and C than in group A (p < 0.01). The difference between groups B and C was not statistically significant. Although all group C patients developed severe pain after TAE, the pain was controlled with analgesics. Thrombocytopenia occurred in 6 of 17 (35%) group B patients.
Conclusion:
Group B and C patients had better tumor reduction than those in group A. Fewer hematologic complications occurred in group C patients compared with group B.
Similar content being viewed by others
References
Panici PB, Scambia G, Baiocchi G (1991) Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Cancer 67:372–379
Sananes C, Giaroli A, Soderini A (1998) Neoadjuvant chemotherapy followed by radical hysterectomy and postoperative adjuvant chemotherapy in the treatment of carcinoma of the cervix uteri: Long-term follow-up of a pilot study. Eur J Gynaecol Oncol 19:368–373
Whitney CW, Sause W, Bundy BN (1999) Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB–IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17:1339–1348
Panici PB, Landoni F, Greggi S (1997) Randomized trial of neoadjuvant chemotherapy followed by radical surgery vs exclusive radiotherapy in locally advanced squamous cell cervical cancer. An Italian multicenter study [abstract]. Proc Soc Gynecol Oncol 38:212–216
Sardi JE, Sanaes CE, Giaroli AA (1998) Neoadjuvant chemotherapy in cervical carcinoma stage IIB: A randomized controlled trial. Int J Gynecol Cancer 8:441–450
Cervellino JC, Araujo CE, Sanchez O, Miles H, Nishihama A (1995) Cisplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix. A phase II trial. Acta Oncol 34:257–259
Pignata S, Silvestro G, Ferrari E (1999) Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix. J Clin Oncol 17:756–760
Kigawa J, Minagawa Y, Ishihara H (1996) The role of neoadjuvant intraarterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cancer. Am J Clin Oncol 19:255–259
Mitty HA, Sterling KM, Alvarez M, Gendler R (1993) Obstetric hemorrhage: Prophylactic and emergency arterial catheterization and embolotherapy. Radiology 188:183–187
Vedantham S, Goodwin SC, McLucas B, Mohr G (1997) Uterine embolization: An underused method of controlling pelvic hemorrhage. Am J Obstet Gynecol 176:938–948
Pelage JP, Le Dref O, Mateo J (1998) Life-threatening primary postpartum hemorrhage: Treatment with emergency selective arterial embolization. Radiology 208:359–362
Adachi S, Ogasawara T (2001) Phase I/II study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma. Cancer 91:74–79
Pecorelli S, Benedet JL, Creasman WT, Shepherd JH (1999) FIGO staging of gynecologic cancer. Int J Gynecol Obstet 64:5–10
Giaroli A, Sananes C, Sardi JE, Maya AG, Bastardas ML, Snaidas L, et al (1995) Lymph node metastasis in carcinoma of the cervical uteri: Response to neoadjuvant chemotherapy and its impact on survival. Gynecol Oncol 39:34–39
Orsini L, Salardi S, Pilu G, Bovicelli L, Cacciari E (1984) Pelvic organs in premenarcheal girls: Real-time ultrasonography. Radiology 153:113–116
Millar AB, Hoogstraten B, Staquet M (1981) Reporting results of cancer treatment. Cancer 47:207–214
Sardi J, Sanances C, Giari A, Maya G, Paola G (1990) Neoadjuvant chemotherapy in local advanced carcinoma of the cervix uteri. Gynecol Oncol 38:486–493
Panici PB, Greggi S, Scambia G (1991) High-dose cisplatin and bleomycin neoadjuvant chemotherapy plus radical surgery in locally advanced cervical carcinoma: A preliminary report. Gynecol Oncol 41:212–216
Weiss GR, Liu PY, O’Sullivan J (1992) A randomized phase II trial of trimetrexate or didemnin B for the treatment of metastatic or recurrent squamous carcinoma of the uterine cervix. Gynecol Oncol 45:303–306
Souhami L, Gil R, Allan SE (1990) A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIb carcinoma of the cervix uteri: Response to neoadjuvant chemotherapy and its impact on survival. Gynecol Oncol 39:34–39
Kim D, Moon H, Kim K, Hwang Y, Cho S, Kim S (1989). Two-year survival: Preoperative neoadjuvant chemotherapy in treatment of cervical carcinoma stage IB and II with bulky tumor. Gynecol Oncol 33:225–230
Sarabelli C, Tumolo S, Paoli A (1987) Intermittent pelvic arterial infusion with peptichemo, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervix. Cancer 44:25–30
Lejarcegui JA, Cot X, Lailla JM (1988) Intraarterial infusion chemotherapy as a primary treatment in cancer of uterine cervix limited to the pelvis. Eur J Gynaecol Oncol 5:403–409
Itoh N, Sawairi M, Hanabayashi T, Mori H, Yamawaki Y, Tamaya T (1992) Neoadjuvant intraarterial infusion chemotherapy with combination of mitomycin-C, vincristine, and cisplatin for locally advanced cervical cancer: A preliminary report. Gynecol Oncol 47:391–394
Okada S, (1998) Transcatheter arterial embolization for advanced hepatocellular carcinoma: The controversy continues [editorial]. Hepatology 27:1743–1744
Kan Z, Sato M, Ivancev K, Uchida B, Hedgpeth P, Lunderquist A, Rosch J, Yamada R (1993) Distribution and effect of iodized poppyseed oil in the liver after hepatic artery embolization: Experimental study in several animal species. Radiology 186:861–866
Roul JL, Bourguet P, Bretagne JF, Duvauferrier R, Coornaert S, Darnault P, Ramee A, Herry JY, Gastard J (1988) Hepatic artery injection of I-131-labeled lipiodol. I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology 168:541–545
Bruix J, Castells A, Montanya X, Calvet X, Bru C, Ayuso C, Jover L, Garcia L, Vilana R, Boix LI (1994) Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: Need for controlled trials. Hepatology 20:643–650
Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K (1991) Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. Cancer 68:2150–2154
Bronowicki JP, Boudjema K, Chone L, Nisand G, Bazin C, Pflumio F, Uhl G, Wenger JJ, Jaeck D, Boissel P, Bigard MA, Gaucher P, Vetter D, Doffoel M (1996) Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma. J Hepatology 24:293–300
Farinati F, De Maria N, Marafin C (1996) Unresectable hepatocellular carcinoma in cirrhosis. Dig Dis Sci 14:2332–2339
Hashii K, Tateyama I, Mori T, Harima K, Harima Y (1992) Evaluation of preoperative intraarterial chemotherapy in combination with transcatheter arterial embolization in case of advanced cervical cancer [in Japanese]. J Jpn Soc Cancer Ther 27:695–705
Correll JT, Prentice HR, Wise EC (1945) Biologic investigations of a new absorbable sponge. Surg Gynecol Obstet 81:585–589
Jenkins HP, Janda R, Clarke J (1946) Clinical and experimental observations on the use of gelatin sponge or foam. Surgery 20:124–132
Vlahos L, Benakis V, Dimakakos P, Dimopoulos C, Pontifex G (1980) A comparative study of the degree of arterial recanalization in kidneys of dogs following transcatheter embolization with eight different materials. Eur Urol 6:180–185
Sniderman KW, Sos TA, Alonso DR (1981) Transcatheter embolization with Gelfoam and Avitene: The effect of Sotradecol on the duration of arterial occlusion. Invest Radiol 16:501–507
Jander HP, Russinovich NA (1980) Transcatheter Gelfoam embolization in abdominal, retroperitoneal, and pelvic hemorrhage. Radiology 136:337–344
Fuller AF Jr, Elliott N, Kosloff C, Lewis JL Jr (1982) Lymph node metastasis of carcinoma of the cervix stage IB–IIA: Implication for prognosis and treatment. Gynecol Oncol 13:165–174
Adachi S, Ogasawara T, Wakimoto E (2001) Phase I/II study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma. Cancer 91:74–79
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ikeda, O., Mizukami, N., Murata, Y. et al. Randomized Comparison of Intra-Arterial Chemotherapy Versus Intra-Arterial Chemotherapy and Gelfoam Embolization for Treatment of Advanced Cervical Carcinoma. Cardiovasc Intervent Radiol 28, 736–743 (2005). https://doi.org/10.1007/s00270-004-4178-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-004-4178-z